P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. (23rd June 2022) - Dodero, A.; Guidetti, A.; Lorenzoni, A.; Pizzamiglio, S.; Argiroffi, G.; Verderio, P.; Chiappella, A.; Bagnoli, F.; Carniti, C.; Pennisi, M.; Alessi, A.; Corradini, P.